Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02352558
Title A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

hematologic cancer

Therapies

Imatinib

Napabucasin

Bortezomib

Ibrutinib

Dexamethasone

Age Groups: adult
Covered Countries USA


No variant requirements are available.